Opportunity
CanadaBuys #LL 03-26-1123
McMaster University requests PET and SPECT preclinical imaging systems for radiopharmaceutical research.
Posted
June 23, 2026
Respond By
July 23, 2026
Identifier
LL 03-26-1123
NAICS
334510
McMaster University is seeking vendors to supply advanced PET and SPECT preclinical imaging systems for its Institute for Radiopharmaceutical Imaging and Therapy (MIRIT). - Government Buyer: - McMaster University, Hamilton, Ontario - McMaster Institute for Radiopharmaceutical Imaging and Therapy (MIRIT) - Products/Services Requested: - PET and SPECT preclinical imaging systems - Must support quantitative imaging and dosimetry for therapeutic isotopes (e.g., Lu-177, Tb-161) - Designed for use with live animals (rats and mice) - Enables in vivo validation of novel tracers and therapeutics - Supports research in oncology, neurology, cardiology, and inflammation - Unique/Notable Requirements: - Systems must facilitate regulatory and clinical translation - One-time acquisition with a 1-year warranty, extendable up to 3 years - Open competitive bidding governed by Canadian and international trade agreements - OEMs and Vendors: - No specific OEMs or vendors named in the solicitation - Quantities and Part Numbers: - No specific quantities or part numbers provided
Description
McMaster University is soliciting bids for the supply of PET and SPECT preclinical imaging systems capable of quantitative imaging and dosimetry for therapeutic isotopes on live animals. These systems will support radiopharmaceutical and theranostics research, enabling in vivo validation of novel tracers and therapeutics, and facilitating regulatory and clinical translation. The procurement includes a one-time purchase with a 1-year warranty and options to extend up to 3 years. The systems will support multidisciplinary projects in oncology, neurology, cardiology, and inflammation.